| 摘要 |
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes. |
| 申请人 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);UNIVERSITE DE MONTPELLIER I;UNIVERSITE MONTPELLIER II;UNIVERSITY OF PARMA;ECOLE NATIONALE SUPERIEURE DE CHIMIE |
发明人 |
CROS, GÉRARD;CROZIER, ALAN;DALL'ASTA, MARGHERITA;DEL RIO, DANIELE;MAGOUS, RICHARD;OIRY, CATHERINE |
